Author:
Yamamoto Yumi,Danhof Meindert,de Lange Elizabeth C. M.
Publisher
Springer Science and Business Media LLC
Reference192 articles.
1. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004;3:1–5.
2. Hurko O, Ryan JL. Translational research in central nervous system drug discovery. J Am Soc Exp Neurother. 2005;2(4):671–82.
3. Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, et al. Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov. 2014;13(6):419–31.
4. De Lange ECM. The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects. Fluids Barriers CNS. 2013;10(1):1–16.
5. Palmer AM, Stephenson FA. CNS drug discovery: challenges and solutions. Drug News Perspect. 2005;18(1):51–7.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献